is farxiga a glp 1 agonist GLP-1: Actions on Beta-cell Mass and Function Mapping the effectiveness and risks
Description
[DOI] [PubMed] [Google Scholar] 108.Melson E., Ashraf U., Papamargaritis D., Davies M.J
Myocardial remodelling characterized by fibrosis and hypertrophy, impaired microcirculation, abnormal protein function caused by advanced glycation end products, changes in myocardial metabolism and abnormal mitochondrial function have been noted as associated factors of diabetic cardiomyopathy [14]
%25201.png)
However, efficacy in these latter indications remains under investigation
Verify current pricing directly on the TeleHealth Med site before enrolling, as promotional rates can change
2019;10:p
The Lancet 402 , 613626 (2023)
